Literature DB >> 9167781

Reoperation for recurrent trigeminal neuralgia after microvascular decompression.

J J Liao1, W C Cheng, C N Chang, J T Yang, K C Wei, Y H Hsu, T K Lin.   

Abstract

BACKGROUND: Microvascular decompression (MVD) is an effective technique for those who have trigeminal neuralgia (TN) but cannot tolerate, or show no response to medicine. Though the initial success rate is high, some patients may develop severe recurrent neuralgia, especially after a longer period of follow-up. The efficacy of reoperation needs to be evaluated. To know the possible risk factors of recurrence after initial MVD is mandatory to the management of recurrent TN.
METHODS: Among the 80 cases of TN treated with MVD, five cases showed severe recurrent symptoms within a follow-up period from 9 months-4 years. The symptoms recurred on the same side of the face, and were unresponsive to medical treatment. Brain computed tomography (CT) and magnetic resonance imaging (MRI) may reveal the etiology of recurrence. Repeat decompression of the trigeminal nerve was the main goal of reoperation, which was done via a suboccipital approach.
RESULTS: Over the past 17 years, 80 MVDs for TN have been performed at Chang Gung Memorial Hospital. There were five cases of serious postoperative recurrence, which could not be relieved by medicine. Recurrence occurred 1 day-12 months after the initial surgery. Three cases were due to vascular compression, while two were caused by the local effect of Teflon felt. Reoperation produced complete remission in four patients, and partial remission in one.
CONCLUSIONS: An increasing number of patients may experience severe recurrent TN after initial MVD during a long period of follow-up. Reoperation is safe and beneficial for these patients, but the results are dependent on the etiology of the recurrence. Further vascular compression of the trigeminal nerve can be relieved by MVD. Otherwise, in cases of severe adhesion caused by Teflon, complete microneural lysis can achieve satisfactory results.

Entities:  

Mesh:

Year:  1997        PMID: 9167781     DOI: 10.1016/s0090-3019(96)00250-9

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  7 in total

1.  Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis.

Authors:  G Broggi; P Ferroli; A Franzini; D Servello; I Dones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

2.  Vascular Decompression of Trigeminal and Facial Nerves in the Posterior Fossa under Endoscope-Assisted Keyhole Conditions.

Authors:  P Charalampaki; A M Kafadar; P Grunert; A Ayyad; A Perneczky
Journal:  Skull Base       Date:  2008-03

Review 3.  Teflon™ or Ivalon®: a scoping review of implants used in microvascular decompression for trigeminal neuralgia.

Authors:  Elliot Pressman; R Tushar Jha; Gleb Zavadskiy; Jay I Kumar; Harry van Loveren; Jamie J van Gompel; Siviero Agazzi
Journal:  Neurosurg Rev       Date:  2019-11-30       Impact factor: 3.042

4.  Outcome of microvascular decompression for trigeminal neuralgia using autologous muscle graft: A five-year prospective study.

Authors:  Palaniappan Manickam Jagannath; Neelam Krishnan Venkataramana; Abhilash Bansal; Madineni Ravichandra
Journal:  Asian J Neurosurg       Date:  2012-07

5.  Unusual recurrence of trigeminal neuralgia after microvascular decompression by muscle interposal.

Authors:  Giovanni Grasso; Franceso Meli; Rosario Maugeri; Francesco Certo; Gabriele Costantino; Filippo Giambartino; Domenico G Iacopino
Journal:  Med Sci Monit       Date:  2011-04

6.  [Microvascular decompresion for trigeminal neuralgia, report of 36 cases and literature review].

Authors:  Alvaro Campero; Pablo Ajler; Abraham Agustín Campero
Journal:  Surg Neurol Int       Date:  2014-10-13

7.  Reappearance of Cranial Nerve Dysfunction Symptoms Caused by New Artery Compression More than 20 Years after Initially Successful Microvascular Decompression: Report of Two Cases.

Authors:  Hiroto Inoue; Akinori Kondo; Hiroshi Shimano; Soichiro Yasuda; Kenichi Murao
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-01-22       Impact factor: 1.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.